Utilize este identificador para referenciar este registo: https://hdl.handle.net/10316/95927
Título: Immunomodulatory Properties of Umbilical Cord Blood-Derived Small Extracellular Vesicles and Their Therapeutic Potential for Inflammatory Skin Disorders
Autor: Rodrigues, Sílvia C.
Cardoso, Renato M. S.
Freire, Patricia C.
Gomes, Cláudia F.
Duarte, Filipe V. 
Neves, Ricardo Pires das 
Simões-Correia, Joana
Palavras-chave: Umbilical cord blood; Extracellular vesicles; Inflammatory skin disease; Psoriasis
Data: 10-Set-2021
Editora: MDPI
Projeto: SFRH/BD/137633/2018 
CENTRO-01-0247-FEDER-022398 
CENTRO-01-02B7-FEDER-070018 
Título da revista, periódico, livro ou evento: International Journal of Molecular Sciences
Volume: 22
Número: 18
Resumo: Umbilical cord blood (UCB) has long been seen as a rich source of naïve cells with strong regenerative potential, likely mediated by paracrine signals. More recently, small extracellular vesicles (sEV), such as exosomes, have been shown to play essential roles in cell-to-cell communication, via the transport of numerous molecules, including small RNAs. Often explored for their potential as biomarkers, sEV are now known to have regenerative and immunomodulating characteristics, particularly if isolated from stem cell-rich tissues. In this study, we aim to characterize the immunomodulating properties of umbilical cord blood mononuclear cell-derived sEV (UCB-MNC-sEV) and explore their therapeutic potential for inflammatory skin diseases. UCB-MNC-sEV were shown to shift macrophages toward an anti-inflammatory phenotype, which in turn exert paracrine effects on fibroblasts, despite previous inflammatory stimuli. Additionally, the incubation of PBMC with UCB-MNC-sEV resulted in a reduction of total CD4+ and CD8+ T-cell proliferation and cytokine release, while specifically supporting the development of regulatory T-cells (Treg), by influencing FOXP3 expression. In a 3D model of psoriatic skin, UCB-MNC-sEV reduced the expression of inflammatory and psoriatic markers IL6, IL8, CXCL10, COX2, S100A7, and DEFB4. In vivo, UCB-MNC-sEV significantly prevented or reversed acanthosis in imiquimod-induced psoriasis, and tendentially increased the number of Treg in skin, without having an overall impact on disease burden. This work provides evidence for the anti-inflammatory and tolerogenic effect of UCB-MNC-sEV, which may be harnessed for the treatment of Th17-driven inflammatory skin diseases, such as psoriasis.
URI: https://hdl.handle.net/10316/95927
ISSN: 1422-0067
DOI: 10.3390/ijms22189797
Direitos: openAccess
Aparece nas coleções:IIIUC - Artigos em Revistas Internacionais

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato
ijms-22-09797-v2.pdf1.81 MBAdobe PDFVer/Abrir
Mostrar registo em formato completo

Citações SCOPUSTM   

11
Visto em 18/mar/2024

Citações WEB OF SCIENCETM

8
Visto em 2/mar/2024

Visualizações de página

114
Visto em 26/mar/2024

Downloads

93
Visto em 26/mar/2024

Google ScholarTM

Verificar

Altmetric

Altmetric


Este registo está protegido por Licença Creative Commons Creative Commons